• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人胚胎干细胞系的分离、培养和鉴定。

Human embryonic stem cell lines isolation, cultivation, and characterization.

机构信息

Vavilov Institute of General Genetics RAS, Gubkina str., 3, 119991 Moscow, Russia.

出版信息

In Vitro Cell Dev Biol Anim. 2010 Apr;46(3-4):284-93. doi: 10.1007/s11626-010-9282-6. Epub 2010 Feb 23.

DOI:10.1007/s11626-010-9282-6
PMID:20178000
Abstract

A large number of human embryonic stem cell (hESC) lines have been derived worldwide since the first hESC line establishment in 1998. Despite many common characteristics, most important of which is the pluripotency, hESC lines vary significantly in their transcriptional profiles, genetic, and epigenetic state. These differences may arise both from individual genetics of the cell lines and from variations in their handling such as isolation and cultivation. In order to minimize the latter differences, the standardized protocols of cultivation and inter-laboratory comprehensive studies should be performed. In this report, we summarized our experience of derivation and characterization of hESC lines as well as of adaptation of hESCs to novel cultivation protocols. We have successfully derived five hESC lines and characterized them by previously established criteria, including expression of specific markers and the capacity to differentiate both in vitro and in vivo. Four of these lines, namely hESM01-04, were initially derived using mouse fibroblasts as a feeder and currently are maintained under feeder-free, serum-free conditions using mTeSR1 and Matrigel. The fifth line, hESMK05 was derived in feeder-free, serum-free conditions using mTeSR1 and Matrigel. Cell lines retain their pluripotent status and normal karyotype for more than 70 passages and are available to the scientific community.

摘要

自 1998 年首例人类胚胎干细胞(hESC)系建立以来,全世界已经衍生出了大量的 hESC 系。尽管大多数 hESC 系具有许多共同的特征,其中最重要的是多能性,但它们在转录谱、遗传和表观遗传状态方面存在显著差异。这些差异可能既来自细胞系的个体遗传学,也来自于它们在分离和培养等方面的处理差异。为了最大限度地减少后者的差异,应该采用标准化的培养方案和实验室间的综合研究。在本报告中,我们总结了我们在 hESC 系的衍生和特征描述以及 hESC 适应新的培养方案方面的经验。我们已经成功衍生了五个 hESC 系,并通过已建立的标准对其进行了特征描述,包括特定标志物的表达以及体外和体内分化的能力。这四个系,即 hESM01-04,最初是使用小鼠成纤维细胞作为饲养细胞衍生的,目前在无饲养细胞、无血清的条件下使用 mTeSR1 和 Matrigel 维持。第五个系 hESMK05 在无饲养细胞、无血清的条件下使用 mTeSR1 和 Matrigel 衍生。细胞系保持其多能状态和正常核型超过 70 代,并可供科学界使用。

相似文献

1
Human embryonic stem cell lines isolation, cultivation, and characterization.人胚胎干细胞系的分离、培养和鉴定。
In Vitro Cell Dev Biol Anim. 2010 Apr;46(3-4):284-93. doi: 10.1007/s11626-010-9282-6. Epub 2010 Feb 23.
2
Establishment of clinically compliant human embryonic stem cells in an autologous feeder-free system.建立临床兼容的自体无饲养层人类胚胎干细胞系。
Tissue Eng Part C Methods. 2011 Sep;17(9):927-37. doi: 10.1089/ten.TEC.2010.0735. Epub 2011 Jun 20.
3
Generation of Sheffield (Shef) human embryonic stem cell lines using a microdrop culture system.使用微滴培养系统生成谢菲尔德(Shef)人类胚胎干细胞系。
In Vitro Cell Dev Biol Anim. 2010 Apr;46(3-4):236-41. doi: 10.1007/s11626-010-9294-2. Epub 2010 Mar 12.
4
Autogeneic feeders for the culture of undifferentiated human embryonic stem cells in feeder and feeder-free conditions.用于在有饲养层和无饲养层条件下培养未分化人胚胎干细胞的自体饲养层。
Methods Cell Biol. 2008;86:15-28. doi: 10.1016/S0091-679X(08)00002-2.
5
Efficient culture system for human embryonic stem cells using autologous human embryonic stem cell-derived feeder cells.使用自体人胚胎干细胞衍生的饲养层细胞的人胚胎干细胞高效培养系统。
Exp Mol Med. 2005 Oct 31;37(5):399-407. doi: 10.1038/emm.2005.50.
6
Derivation and characterization of three new human embryonic stem cell lines in Finland.在芬兰建立了三株人胚胎干细胞系的建立和鉴定。
In Vitro Cell Dev Biol Anim. 2010 Apr;46(3-4):206-9. doi: 10.1007/s11626-010-9286-2. Epub 2010 Feb 23.
7
Characterization of six new human embryonic stem cell lines (HSF7, -8, -9, -10, -12, and -13) derived under minimal-animal component conditions.在最少动物成分条件下衍生的六种新人类胚胎干细胞系(HSF7、-8、-9、-10、-12和-13)的特征分析。
Stem Cells Dev. 2008 Jun;17(3):535-46. doi: 10.1089/scd.2007.0216.
8
Defined and serum-free media support undifferentiated human embryonic stem cell growth.定义的无血清培养基支持未分化的人胚胎干细胞生长。
Stem Cells Dev. 2010 Jun;19(6):753-61. doi: 10.1089/scd.2009.0210.
9
Growth of human embryonic stem cells using derivates of human fibroblasts.利用人成纤维细胞衍生物培养人胚胎干细胞。
Methods Mol Biol. 2010;584:55-69. doi: 10.1007/978-1-60761-369-5_3.
10
Establishment and characterization of human embryonic stem cell lines, Turkey perspectives.人胚胎干细胞系的建立与鉴定,土耳其视角。
In Vitro Cell Dev Biol Anim. 2010 Apr;46(3-4):345-55. doi: 10.1007/s11626-010-9299-x. Epub 2010 Mar 27.

引用本文的文献

1
Robust protocol for feeder-free adaptation of cryopreserved human pluripotent stem cells.无饲养层条件下冻存人多能干细胞适应方法的优化
In Vitro Cell Dev Biol Anim. 2019 Dec;55(10):777-783. doi: 10.1007/s11626-019-00413-9. Epub 2019 Oct 29.
2
Substrates for clinical applicability of stem cells.干细胞临床应用的基质。
World J Stem Cells. 2015 Mar 26;7(2):243-52. doi: 10.4252/wjsc.v7.i2.243.
3
No DNA damage response and negligible genome-wide transcriptional changes in human embryonic stem cells exposed to terahertz radiation.

本文引用的文献

1
CD 30 is a marker of undifferentiated human embryonic stem cells rather than a biomarker of transformed hESCs.CD30是未分化人类胚胎干细胞的标志物,而非转化的人胚胎干细胞的生物标志物。
Cell Cycle. 2008 Nov 15;7(22):3610-2. doi: 10.4161/cc.7.22.6981.
2
Novel noncoding antisense RNA transcribed from human anti-NOS2A locus is differentially regulated during neuronal differentiation of embryonic stem cells.从人类抗一氧化氮合酶2A基因座转录而来的新型非编码反义RNA在胚胎干细胞神经元分化过程中受到差异调控。
RNA. 2008 Oct;14(10):2030-7. doi: 10.1261/rna.1084308.
3
Efficient differentiation of hESCs into endothelial cells in vitro is secured by epigenetic changes.
暴露于太赫兹辐射的人类胚胎干细胞未出现DNA损伤反应,全基因组转录变化可忽略不计。
Sci Rep. 2015 Jan 13;5:7749. doi: 10.1038/srep07749.
4
Reactivation of Х chromosome upon reprogramming leads to changes in the replication pattern and 5hmC accumulation.重编程过程中X染色体的重新激活会导致复制模式的改变和5-羟甲基胞嘧啶(5hmC)的积累。
Chromosoma. 2014 Mar;123(1-2):117-28. doi: 10.1007/s00412-013-0433-x. Epub 2013 Aug 28.
5
Late replication of the inactive x chromosome is independent of the compactness of chromosome territory in human pluripotent stem cells.人类多能干细胞中失活 X 染色体的晚期复制与染色体区室的紧密程度无关。
Acta Naturae. 2013 Apr;5(2):54-61.
6
Culture conditions affect cardiac differentiation potential of human pluripotent stem cells.培养条件影响人多能干细胞的心脏分化潜能。
PLoS One. 2012;7(10):e48659. doi: 10.1371/journal.pone.0048659. Epub 2012 Oct 31.
7
Error-prone nonhomologous end joining repair operates in human pluripotent stem cells during late G2.易错非同源末端连接修复在人多能干细胞的G2晚期发挥作用。
Aging (Albany NY). 2011 Jun;3(6):584-96. doi: 10.18632/aging.100336.
通过表观遗传变化确保了人胚胎干细胞(hESCs)在体外高效分化为内皮细胞。
Cell Cycle. 2008 Sep 15;7(18):2929-35. doi: 10.4161/cc.7.18.6700.
4
Cultures of hESM human embryonic stem cells: chromosomal aberrations and karyotype stability.人胚胎干细胞系(hESM)的培养:染色体畸变与核型稳定性
Bull Exp Biol Med. 2007 Jul;144(1):126-9. doi: 10.1007/s10517-007-0271-z.
5
Characterization of human embryonic stem cell lines by the International Stem Cell Initiative.国际干细胞研究协会对人类胚胎干细胞系的特征描述
Nat Biotechnol. 2007 Jul;25(7):803-16. doi: 10.1038/nbt1318. Epub 2007 Jun 17.
6
Adaptation to culture of human embryonic stem cells and oncogenesis in vivo.人胚胎干细胞的培养适应性与体内肿瘤发生
Nat Biotechnol. 2007 Feb;25(2):207-15. doi: 10.1038/nbt1285.
7
Culture conditions for human embryonic stem cells.人类胚胎干细胞的培养条件。
Reproduction. 2006 Nov;132(5):691-8. doi: 10.1530/rep.1.01079.
8
Differences between human embryonic stem cell lines.人类胚胎干细胞系之间的差异。
Hum Reprod Update. 2007 Mar-Apr;13(2):103-20. doi: 10.1093/humupd/dml041. Epub 2006 Aug 26.
9
Distinct differentiation characteristics of individual human embryonic stem cell lines.个体人类胚胎干细胞系的独特分化特征。
BMC Dev Biol. 2006 Aug 8;6:40. doi: 10.1186/1471-213X-6-40.
10
Derivation of a xeno-free human embryonic stem cell line.无动物成分人胚胎干细胞系的衍生
Stem Cells. 2006 Oct;24(10):2170-6. doi: 10.1634/stemcells.2006-0130. Epub 2006 Jun 1.